Pancreatic cancer remains one of the biggest challenges in the field of oncology. Numbers of cases are increasing, and the latest personalized therapies and immunotherapy are not yet yielding results.

For patients with nonhealing ulcers or persistent lesions, additional treatment adjuncts were required. These included ...

Patients with bone metastasis had a lower risk of death with immunotherapy alone or with immunotherapy plus surgery than with surgery alone. The survival benefits observed with different treatments ...

Representative CT and MRI images demonstrate pancreatic metastases originating from clear cell renal carcinoma, lung cancer, and other malignancies. Understanding these imaging patterns is essential ...

The U.S. Food and Drug Administration (FDA) has approved pembrolizumab, an immunotherapy, plus belzutifan, a HIF-2α inhibitor ...

Combining surgery with chemotherapy significantly improves survival in GIST patients with liver metastases compared to chemotherapy alone. Median CSS and OS for combined treatment exceed 120 months, ...

Patients undergoing stereotactic radiosurgery before resection of brain metastases demonstrated low rates of local recurrence, radionecrosis, and nodular leptomeningeal disease at 12 and 24 months, a ...

CHICAGO -- Liver transplantation for unresectable colorectal cancer (CRC) liver metastases led to dramatic improvement in long-term survival, French investigators reported. Five-year overall survival ...

Surgery and chemotherapy significantly improved both overall survival (OS) and cancer-specific survival (CSS) in patients with liver metastases originating from ovarian cancer (OC), who generally face ...

Metastatic endometrial cancer can affect distant areas of the body, such as the lungs, liver, bones, or brain. Treatments may include surgery alongside radiation therapy, chemotherapy, or other drugs.